1.12

6.67% 0.07

After Hours: 1.14 0.02 +1.79%

Mira Pharmaceuticals Inc (MIRA)

Overview News Price History Discussions Forecast

Mira Pharmaceuticals Inc stock is traded at $1.12, with a volume of 127.91K. It is up +6.67% in the last 24 hours and down -11.81% over the past month. Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Previous Close:

$1.05

Open:

$1.08

24h Volume:

127.91K

Relative Volume:

0.74

Market Cap:

$46.90M

Revenue:

Net Income/Loss:

$-28.42M

P/E Ratio:

-0.736

EPS:

-1.5218

Net Cash Flow:

$-5.33M

1W Performance:

+0.90%

1M Performance:

-11.81%

6M Performance:

-13.85%

1Y Performance:

-8.20%

1-Day Range:

$1.08

$1.165

1-Week Range:

$0.90

$1.165

52-Week Range:

$0.73

$2.45

Mira Pharmaceuticals Inc Stock (MIRA) Company Profile

Name

Mira Pharmaceuticals Inc

Sector

Healthcare (1114)

Industry

Drug Manufacturers - General (20)

Phone

813-369-5150

Address

1200 BRICKELL AVENUE, MIAMI

Employee

Twitter

Next Earnings Date

2026-03-27

Latest SEC Filings

MIRA's Discussions on Twitter

Compare MIRA vs LLY, JNJ, ABBV, MRK, AZN

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MIRA Mira Pharmaceuticals Inc	1.12	43.97M	0	-28.42M	-5.33M	-1.5218
LLY Lilly Eli Co	916.31	806.39B	65.18B	20.64B	5.96B	22.59
JNJ Johnson Johnson	239.93	566.67B	94.19B	26.80B	19.70B	11.05
ABBV Abbvie Inc	207.18	362.83B	61.16B	4.19B	17.82B	2.3614
MRK Merck Co Inc	119.37	287.71B	64.93B	18.26B	12.36B	7.2751
AZN Astrazeneca Plc	187.14	288.11B	58.80B	10.24B	8.98B	3.2788

Mira Pharmaceuticals Inc Stock (MIRA) Latest News

Mar 25, 2026

Mira Pharmaceuticals, Inc. Announces Positive Preclinical Results for Mira-55, a Non-Opioid Pain and Anxiety Treatment - Minichart

Mar 23, 2026

MIRA’s Mira-55 shows no CNS side effects in preclinical tests - Investing.com

Mar 23, 2026

Mira Pharmaceuticals reports preclinical results for Mira-55 with no observed THC- or rimonabant-like CNS side effects - Investing.com

Mar 23, 2026

MIRA Pharmaceuticals Reports Mira-55 Shows No THC- or Rimonabant-Associated CNS Side Effects in Preclinical Studies - ACCESS Newswire

Mar 23, 2026

MIRA Pharmaceuticals (MIRA) posts Mira-55 CNS and pain preclinical data - Stock Titan

Mar 23, 2026

MIRA pain drug showed morphine-like relief without THC-like effects - Stock Titan

Mar 23, 2026

Mar 22, 2026

Aug EndMonth: What is the Moat Score of MIRA Pharmaceuticals Inc2026 Macro Moves & Weekly Return Optimization Plans - baoquankhu1.vn

Mar 22, 2026

Mar 20, 2026

Momentum Shift: Can MIRA Pharmaceuticals Inc maintain its current growth rateRate Cut & Precise Swing Trade Alerts - baoquankhu1.vn

Mar 20, 2026

Macro Review: Can MIRA Pharmaceuticals Inc maintain its current growth rateTrade Ideas & Reliable Price Breakout Signals - baoquankhu1.vn

Mar 20, 2026

Mar 18, 2026

Dividend Watch: Can MIRA Pharmaceuticals Inc deliver alphaQuarterly Profit Report & Advanced Swing Trade Entry Plans - baoquankhu1.vn

Mar 18, 2026

Mar 17, 2026

Short Interest in MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Drops By 13.9% - MarketBeat

Mar 17, 2026

Mar 13, 2026